Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
23 November 2022 | Story André Damons

The Department of Pharmacology at the University of the Free State (UFS), together with the Technology Innovation Agency (TIA), is hosting the first Indigenous Knowledge and Bio-Trade Indaba on the Bloemfontein Campus. The Department of Science and Innovation (DSI) and TIA are the sponsors of the event. 

Prof Motlalepula Matsabisa, Professor and Director of Pharmacology, will play host to the various stakeholders to network and share knowledge on current developments in indigenous knowledge research and product development, biodiversity, innovation, and commercialisation of the IK-based research products. The Indigenous Knowledge System (IKS) for Health unit in the Department of Pharmacology within the UFS Faculty of Health Sciences was last year awarded an annual Technology Innovation Agency Platform (TIA) grant of R17 million for the next five years.

The research and teaching programme in the School of Clinical Medicine has since been rebranded and is now known as the African Medicines Innovation and Technology Development Platform (AMITD), which will strive to respond to community health needs and address industry research needs and challenges.

The indaba will showcase progress made by TIA and other entities in enriching the development and commercialisation of IK-based innovations. It will take place from 24 to 25 November 2022 in the Equitas Senate Hall at the UFS. 

Prof Matsabisa is the chairperson of the World Health Organisation’s (WHO) Regional Expert Advisory Committee on Traditional Medicines for COVID-19. He is also a visiting professor at the Beijing University of Chinese Medicine (BUCM) in Beijing, China, and the Deputy President of the South African Society for Basic and Clinical Pharmacology.
 

News Archive

Louzanne Coetzee heading for Paralympic Games in Rio
2016-08-02

Description: Louzanne Coetzee  Tags: Louzanne Coetzee

Louzanne Coetzee (left) from the University of the
Free State and her guide Khothatso Mokone, a former Kovsie,
will compete in the Paralympic Games in Rio de Janeiro,
Brazil, from 7 to 18 September 2016.
Photo: Rufus Botha

Her perseverance and faith. Faith in herself and her coaches, as well as her Christian faith. Rufus Botha says this is what makes the Paralympic athlete Louzanne Coetzee special. According to her coach, the 23-year-old star from the University of the Free State (UFS) is easy to work with. “Her work ethic is incredible. As coach, I actually have to stop her,” he jokes. “She does not like to rest.”

On 19 July 2016, Coetzee was included in South Africa’s Paralympic team for the Olympics in Rio de Janeiro, Brazil. She and her guide Khothatso Mokone, also a former Kovsie, were included in the team that will participate in Rio from 7 to 18 September 2016.

Sights still set on 2020 Olympics

In Brazil, Coetzee will compete in the T11 category in the 1 500 m. The blind athlete is also outstanding in the 800 m and 5 000 m, of which she is the world record holder, but these items do not feature at the Olympics.

Botha says Coetzee has her sights still set on the 2020 Paralympic Games in Tokyo, Japan. “Anything she achieves in Rio will actually be a bonus.” He says it was an achievement on its own to be included in the SA team among established athletes such as Arnu Fourie and Ilse (Hayes) Carstens.

CUADS super proud of record-breaker

“Anything she achieves in Rio
will actually be a bonus.”


“Louzanne is an absolute star and an example to so many Kovsie students,” says Martie Miranda, Head of the Centre for Universal Access and Disability Support (CUADS) at the UFS. “We are super proud of her.”

On 17 July 2016, Coetzee set a new Africa record (5:00:25) in the 1 500 m in Berlin. She will leave for Rio on 30 August 2016, with her heat taking place on 15 September 2016 and the finals on 17 September 2016.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept